BACKGROUND: To analyze peripheral non-cutaneous T-cell lymphomas (NC-TCL) a
nd to test the significance of the IPI.
PATHIENS AND METHODS: Twenty-nine consecutive patients diagnosed with NC-TC
L according to the REAL classification.
RESULTS: At diagnosis were common: 8 symptoms (21%), stage III/IV (55%), hi
gh LDH level (55%) and extranodal involvement (79%). Twelve (48%) patients
achieved complete remission. The IPI identified groups of patients with dif
ferent response to therapy and survival,
CONCLUSIONS: NC-TCL with high or high-intermediate IPI had a short survival
if treated with CHOP.